13.37 USD
-0.64 (-4.57%)
At close: Jan 29, 2026
13.1888 USD
-0.18 (-1.36%)
Pre-Market: 1/30/2026, 8:57:19 AM
We assign a fundamental rating of 3 out of 10 to TENX. TENX was compared to 525 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for TENX as it has an excellent financial health rating, but there are worries on the profitability. TENX has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- In the past year TENX has reported negative net income.
- TENX had a negative operating cash flow in the past year.
- In the past 5 years TENX always reported negative net income.
- TENX had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- TENX has a Return On Assets of -42.14%. This is comparable to the rest of the industry: TENX outperforms 57.71% of its industry peers.
- TENX has a Return On Equity of -45.03%. This is in the better half of the industry: TENX outperforms 69.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -42.14% | ||
| ROE | -45.03% | ||
| ROIC | N/A |
ROA(3y)-136.22%
ROA(5y)-220.51%
ROE(3y)-284.78%
ROE(5y)-368.86%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for TENX so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The number of shares outstanding for TENX has been increased compared to 1 year ago.
- TENX has more shares outstanding than it did 5 years ago.
- TENX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 2.40 indicates that TENX is not a great score, but indicates only limited risk for bankruptcy at the moment.
- With a decent Altman-Z score value of 2.40, TENX is doing good in the industry, outperforming 67.62% of the companies in the same industry.
- There is no outstanding debt for TENX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.4 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- TENX has a Current Ratio of 15.58. This indicates that TENX is financially healthy and has no problem in meeting its short term obligations.
- With an excellent Current ratio value of 15.58, TENX belongs to the best of the industry, outperforming 92.38% of the companies in the same industry.
- A Quick Ratio of 15.58 indicates that TENX has no problem at all paying its short term obligations.
- TENX's Quick ratio of 15.58 is amongst the best of the industry. TENX outperforms 92.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 15.58 | ||
| Quick Ratio | 15.58 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 93.76% over the past year.
EPS 1Y (TTM)93.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-110.53%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- TENX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.49% yearly.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y73.69%
EPS Next 2Y30.36%
EPS Next 3Y20.2%
EPS Next 5Y14.49%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for TENX. In the last year negative earnings were reported.
- Also next year TENX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as TENX's earnings are expected to grow with 20.20% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.36%
EPS Next 3Y20.2%
5. Dividend
5.1 Amount
- TENX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TENAX THERAPEUTICS INC / TENX FAQ
What is the ChartMill fundamental rating of TENAX THERAPEUTICS INC (TENX) stock?
ChartMill assigns a fundamental rating of 3 / 10 to TENX.
What is the valuation status of TENAX THERAPEUTICS INC (TENX) stock?
ChartMill assigns a valuation rating of 1 / 10 to TENAX THERAPEUTICS INC (TENX). This can be considered as Overvalued.
What is the profitability of TENX stock?
TENAX THERAPEUTICS INC (TENX) has a profitability rating of 1 / 10.
Can you provide the expected EPS growth for TENX stock?
The Earnings per Share (EPS) of TENAX THERAPEUTICS INC (TENX) is expected to grow by 73.69% in the next year.